This exclusive mechanism induces a synergistic impact with enhanced insulin response and glucagonostatic activity, vs . GIP or GLP-one therapy by yourself. Abstract Tirzepatide is a whole new molecule able to managing glucose blood levels by combining the dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-one) receptors. https://eduardodvmcu.izrablog.com/28612897/reddit-research-chemicals-no-further-a-mystery